nodes	percent_of_prediction	percent_of_DWPC	metapath
Bethanechol—Salivation—Irinotecan—pancreatic cancer	0.0337	0.0514	CcSEcCtD
Bethanechol—Miosis—Irinotecan—pancreatic cancer	0.0312	0.0477	CcSEcCtD
Bethanechol—Abdominal cramps—Tamoxifen—pancreatic cancer	0.0274	0.0418	CcSEcCtD
Bethanechol—Lacrimation—Irinotecan—pancreatic cancer	0.0222	0.0339	CcSEcCtD
Bethanechol—Lacrimation—Fluorouracil—pancreatic cancer	0.0213	0.0324	CcSEcCtD
Bethanechol—Abdominal cramps—Irinotecan—pancreatic cancer	0.0193	0.0295	CcSEcCtD
Bethanechol—Lacrimation increased—Sunitinib—pancreatic cancer	0.0172	0.0262	CcSEcCtD
Bethanechol—Eructation—Sunitinib—pancreatic cancer	0.0156	0.0238	CcSEcCtD
Bethanechol—Lacrimation—Docetaxel—pancreatic cancer	0.0153	0.0234	CcSEcCtD
Bethanechol—Lacrimation increased—Irinotecan—pancreatic cancer	0.0142	0.0216	CcSEcCtD
Bethanechol—Lacrimation increased—Fluorouracil—pancreatic cancer	0.0136	0.0207	CcSEcCtD
Bethanechol—Salivary hypersecretion—Irinotecan—pancreatic cancer	0.0127	0.0193	CcSEcCtD
Bethanechol—Lacrimation—Epirubicin—pancreatic cancer	0.0103	0.0158	CcSEcCtD
Bethanechol—Sweating—Tamoxifen—pancreatic cancer	0.00992	0.0151	CcSEcCtD
Bethanechol—Lacrimation increased—Docetaxel—pancreatic cancer	0.00979	0.0149	CcSEcCtD
Bethanechol—Lacrimation—Doxorubicin—pancreatic cancer	0.00958	0.0146	CcSEcCtD
Bethanechol—Flushing—Tamoxifen—pancreatic cancer	0.00862	0.0132	CcSEcCtD
Bethanechol—Bronchospasm—Gemcitabine—pancreatic cancer	0.00785	0.012	CcSEcCtD
Bethanechol—Feeling hot—Epirubicin—pancreatic cancer	0.00775	0.0118	CcSEcCtD
Bethanechol—Flushing—Sunitinib—pancreatic cancer	0.00738	0.0113	CcSEcCtD
Bethanechol—Feeling hot—Doxorubicin—pancreatic cancer	0.00717	0.011	CcSEcCtD
Bethanechol—Sweating—Irinotecan—pancreatic cancer	0.007	0.0107	CcSEcCtD
Bethanechol—Sweating—Gemcitabine—pancreatic cancer	0.00682	0.0104	CcSEcCtD
Bethanechol—Discomfort—Tamoxifen—pancreatic cancer	0.0068	0.0104	CcSEcCtD
Bethanechol—Lacrimation increased—Epirubicin—pancreatic cancer	0.0066	0.0101	CcSEcCtD
Bethanechol—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00638	0.00974	CcSEcCtD
Bethanechol—Lacrimation increased—Doxorubicin—pancreatic cancer	0.00611	0.00933	CcSEcCtD
Bethanechol—Flushing—Irinotecan—pancreatic cancer	0.00608	0.00928	CcSEcCtD
Bethanechol—Convulsion—Sunitinib—pancreatic cancer	0.006	0.00916	CcSEcCtD
Bethanechol—Eructation—Epirubicin—pancreatic cancer	0.00598	0.00913	CcSEcCtD
Bethanechol—Salivary hypersecretion—Epirubicin—pancreatic cancer	0.00591	0.00902	CcSEcCtD
Bethanechol—Bronchospasm—Docetaxel—pancreatic cancer	0.00557	0.0085	CcSEcCtD
Bethanechol—Eructation—Doxorubicin—pancreatic cancer	0.00553	0.00844	CcSEcCtD
Bethanechol—Salivary hypersecretion—Doxorubicin—pancreatic cancer	0.00547	0.00835	CcSEcCtD
Bethanechol—Ill-defined disorder—Irinotecan—pancreatic cancer	0.00529	0.00808	CcSEcCtD
Bethanechol—Abdominal pain—Tamoxifen—pancreatic cancer	0.00522	0.00796	CcSEcCtD
Bethanechol—Abdominal pain—Erlotinib—pancreatic cancer	0.00516	0.00788	CcSEcCtD
Bethanechol—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.00516	0.00787	CcSEcCtD
Bethanechol—Malaise—Irinotecan—pancreatic cancer	0.00515	0.00785	CcSEcCtD
Bethanechol—Malaise—Gemcitabine—pancreatic cancer	0.00501	0.00765	CcSEcCtD
Bethanechol—Discomfort—Irinotecan—pancreatic cancer	0.0048	0.00733	CcSEcCtD
Bethanechol—Convulsion—Fluorouracil—pancreatic cancer	0.00473	0.00723	CcSEcCtD
Bethanechol—Discomfort—Gemcitabine—pancreatic cancer	0.00468	0.00714	CcSEcCtD
Bethanechol—Discomfort—Fluorouracil—pancreatic cancer	0.0046	0.00702	CcSEcCtD
Bethanechol—Diarrhoea—Tamoxifen—pancreatic cancer	0.00452	0.00689	CcSEcCtD
Bethanechol—Hyperhidrosis—Irinotecan—pancreatic cancer	0.0045	0.00687	CcSEcCtD
Bethanechol—Abdominal pain—Sunitinib—pancreatic cancer	0.00447	0.00682	CcSEcCtD
Bethanechol—Diarrhoea—Erlotinib—pancreatic cancer	0.00447	0.00682	CcSEcCtD
Bethanechol—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00439	0.00669	CcSEcCtD
Bethanechol—Tachycardia—Fluorouracil—pancreatic cancer	0.00435	0.00664	CcSEcCtD
Bethanechol—Hypotension—Irinotecan—pancreatic cancer	0.00435	0.00664	CcSEcCtD
Bethanechol—Hypotension—Gemcitabine—pancreatic cancer	0.00424	0.00647	CcSEcCtD
Bethanechol—Flushing—Docetaxel—pancreatic cancer	0.00421	0.00642	CcSEcCtD
Bethanechol—Hypotension—Fluorouracil—pancreatic cancer	0.00417	0.00636	CcSEcCtD
Bethanechol—Headache—Tamoxifen—pancreatic cancer	0.00413	0.00631	CcSEcCtD
Bethanechol—Headache—Erlotinib—pancreatic cancer	0.00409	0.00624	CcSEcCtD
Bethanechol—Nausea—Tamoxifen—pancreatic cancer	0.00392	0.00598	CcSEcCtD
Bethanechol—Nausea—Erlotinib—pancreatic cancer	0.00388	0.00592	CcSEcCtD
Bethanechol—Diarrhoea—Sunitinib—pancreatic cancer	0.00387	0.0059	CcSEcCtD
Bethanechol—Feeling abnormal—Irinotecan—pancreatic cancer	0.00384	0.00586	CcSEcCtD
Bethanechol—Asthma—Epirubicin—pancreatic cancer	0.00382	0.00583	CcSEcCtD
Bethanechol—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00374	0.00571	CcSEcCtD
Bethanechol—Abdominal pain—Irinotecan—pancreatic cancer	0.00368	0.00562	CcSEcCtD
Bethanechol—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00368	0.00561	CcSEcCtD
Bethanechol—Headache—Sunitinib—pancreatic cancer	0.00354	0.00541	CcSEcCtD
Bethanechol—Asthma—Doxorubicin—pancreatic cancer	0.00353	0.00539	CcSEcCtD
Bethanechol—Pollakiuria—Epirubicin—pancreatic cancer	0.00353	0.00538	CcSEcCtD
Bethanechol—Convulsion—Docetaxel—pancreatic cancer	0.00342	0.00522	CcSEcCtD
Bethanechol—Nausea—Sunitinib—pancreatic cancer	0.00336	0.00513	CcSEcCtD
Bethanechol—Sweating—Epirubicin—pancreatic cancer	0.00326	0.00498	CcSEcCtD
Bethanechol—Pollakiuria—Doxorubicin—pancreatic cancer	0.00326	0.00498	CcSEcCtD
Bethanechol—Diarrhoea—Irinotecan—pancreatic cancer	0.00319	0.00486	CcSEcCtD
Bethanechol—Tachycardia—Docetaxel—pancreatic cancer	0.00314	0.0048	CcSEcCtD
Bethanechol—Diarrhoea—Gemcitabine—pancreatic cancer	0.0031	0.00474	CcSEcCtD
Bethanechol—Diarrhoea—Fluorouracil—pancreatic cancer	0.00305	0.00466	CcSEcCtD
Bethanechol—Sweating—Doxorubicin—pancreatic cancer	0.00302	0.00461	CcSEcCtD
Bethanechol—Hypotension—Docetaxel—pancreatic cancer	0.00301	0.00459	CcSEcCtD
Bethanechol—Headache—Irinotecan—pancreatic cancer	0.00292	0.00445	CcSEcCtD
Bethanechol—Headache—Gemcitabine—pancreatic cancer	0.00284	0.00434	CcSEcCtD
Bethanechol—Flushing—Epirubicin—pancreatic cancer	0.00284	0.00433	CcSEcCtD
Bethanechol—Headache—Fluorouracil—pancreatic cancer	0.00279	0.00426	CcSEcCtD
Bethanechol—Nausea—Irinotecan—pancreatic cancer	0.00277	0.00422	CcSEcCtD
Bethanechol—Nausea—Gemcitabine—pancreatic cancer	0.00269	0.00411	CcSEcCtD
Bethanechol—Feeling abnormal—Docetaxel—pancreatic cancer	0.00265	0.00405	CcSEcCtD
Bethanechol—Nausea—Fluorouracil—pancreatic cancer	0.00265	0.00404	CcSEcCtD
Bethanechol—Flushing—Doxorubicin—pancreatic cancer	0.00262	0.00401	CcSEcCtD
Bethanechol—Abdominal pain—Docetaxel—pancreatic cancer	0.00254	0.00388	CcSEcCtD
Bethanechol—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00247	0.00377	CcSEcCtD
Bethanechol—Malaise—Epirubicin—pancreatic cancer	0.0024	0.00366	CcSEcCtD
Bethanechol—Convulsion—Epirubicin—pancreatic cancer	0.0023	0.00352	CcSEcCtD
Bethanechol—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.00228	0.00349	CcSEcCtD
Bethanechol—Discomfort—Epirubicin—pancreatic cancer	0.00224	0.00342	CcSEcCtD
Bethanechol—Malaise—Doxorubicin—pancreatic cancer	0.00222	0.00339	CcSEcCtD
Bethanechol—Diarrhoea—Docetaxel—pancreatic cancer	0.0022	0.00336	CcSEcCtD
Bethanechol—Convulsion—Doxorubicin—pancreatic cancer	0.00213	0.00326	CcSEcCtD
Bethanechol—Tachycardia—Epirubicin—pancreatic cancer	0.00212	0.00323	CcSEcCtD
Bethanechol—Hyperhidrosis—Epirubicin—pancreatic cancer	0.0021	0.0032	CcSEcCtD
Bethanechol—Discomfort—Doxorubicin—pancreatic cancer	0.00207	0.00316	CcSEcCtD
Bethanechol—Hypotension—Epirubicin—pancreatic cancer	0.00203	0.0031	CcSEcCtD
Bethanechol—Headache—Docetaxel—pancreatic cancer	0.00202	0.00308	CcSEcCtD
Bethanechol—Tachycardia—Doxorubicin—pancreatic cancer	0.00196	0.00299	CcSEcCtD
Bethanechol—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00194	0.00296	CcSEcCtD
Bethanechol—Nausea—Docetaxel—pancreatic cancer	0.00191	0.00292	CcSEcCtD
Bethanechol—Hypotension—Doxorubicin—pancreatic cancer	0.00188	0.00287	CcSEcCtD
Bethanechol—Feeling abnormal—Epirubicin—pancreatic cancer	0.00179	0.00273	CcSEcCtD
Bethanechol—Abdominal pain—Epirubicin—pancreatic cancer	0.00172	0.00262	CcSEcCtD
Bethanechol—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00166	0.00253	CcSEcCtD
Bethanechol—Abdominal pain—Doxorubicin—pancreatic cancer	0.00159	0.00242	CcSEcCtD
Bethanechol—Diarrhoea—Epirubicin—pancreatic cancer	0.00149	0.00227	CcSEcCtD
Bethanechol—Diarrhoea—Doxorubicin—pancreatic cancer	0.00137	0.0021	CcSEcCtD
Bethanechol—Headache—Epirubicin—pancreatic cancer	0.00136	0.00208	CcSEcCtD
Bethanechol—Nausea—Epirubicin—pancreatic cancer	0.00129	0.00197	CcSEcCtD
Bethanechol—Headache—Doxorubicin—pancreatic cancer	0.00126	0.00192	CcSEcCtD
Bethanechol—Nausea—Doxorubicin—pancreatic cancer	0.00119	0.00182	CcSEcCtD
Bethanechol—CHRM3—GPCR downstream signaling—CCK—pancreatic cancer	0.000624	0.00181	CbGpPWpGaD
Bethanechol—CHRM3—Regulation of Actin Cytoskeleton—NRAS—pancreatic cancer	0.000622	0.0018	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—GAST—pancreatic cancer	0.000621	0.0018	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—CCK—pancreatic cancer	0.000618	0.00179	CbGpPWpGaD
Bethanechol—CHRM2—Regulation of Actin Cytoskeleton—NRAS—pancreatic cancer	0.000616	0.00179	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—CNR2—pancreatic cancer	0.000608	0.00176	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000608	0.00176	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—CNR2—pancreatic cancer	0.000602	0.00175	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000602	0.00175	CbGpPWpGaD
Bethanechol—CHRM2—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000601	0.00174	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000598	0.00174	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—SCT—pancreatic cancer	0.000594	0.00172	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000593	0.00172	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—SCT—pancreatic cancer	0.000588	0.00171	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PRLHR—pancreatic cancer	0.000568	0.00165	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—CCK—pancreatic cancer	0.000567	0.00164	CbGpPWpGaD
Bethanechol—CHRM3—Regulation of Actin Cytoskeleton—EGFR—pancreatic cancer	0.000567	0.00164	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PRLHR—pancreatic cancer	0.000563	0.00163	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—CCK—pancreatic cancer	0.000561	0.00163	CbGpPWpGaD
Bethanechol—CHRM2—Regulation of Actin Cytoskeleton—EGFR—pancreatic cancer	0.000561	0.00163	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—ARG2—pancreatic cancer	0.000554	0.00161	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—CNR2—pancreatic cancer	0.000552	0.0016	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—GLP1R—pancreatic cancer	0.000552	0.0016	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—CNR2—pancreatic cancer	0.000547	0.00159	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—GLP1R—pancreatic cancer	0.000547	0.00159	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—CCKAR—pancreatic cancer	0.000543	0.00158	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—IAPP—pancreatic cancer	0.000539	0.00156	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—CCKAR—pancreatic cancer	0.000538	0.00156	CbGpPWpGaD
Bethanechol—CHRM3—Regulation of Actin Cytoskeleton—KRAS—pancreatic cancer	0.000535	0.00155	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ACVR1B—pancreatic cancer	0.000534	0.00155	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ZNRF3—pancreatic cancer	0.000534	0.00155	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—IAPP—pancreatic cancer	0.000534	0.00155	CbGpPWpGaD
Bethanechol—CHRM2—G alpha (i) signalling events—CXCL8—pancreatic cancer	0.000533	0.00155	CbGpPWpGaD
Bethanechol—CHRM2—Regulation of Actin Cytoskeleton—KRAS—pancreatic cancer	0.00053	0.00154	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ZNRF3—pancreatic cancer	0.000529	0.00153	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ACVR1B—pancreatic cancer	0.000529	0.00153	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000517	0.0015	CbGpPWpGaD
Bethanechol—CHRM2—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000515	0.00149	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000512	0.00149	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—SHH—pancreatic cancer	0.000495	0.00144	CbGpPWpGaD
Bethanechol—CHRM3—Regulation of Actin Cytoskeleton—PIK3CA—pancreatic cancer	0.000492	0.00143	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—SHH—pancreatic cancer	0.000491	0.00142	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—IAPP—pancreatic cancer	0.000489	0.00142	CbGpPWpGaD
Bethanechol—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—pancreatic cancer	0.000487	0.00141	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—IAPP—pancreatic cancer	0.000485	0.00141	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—TYMP—pancreatic cancer	0.000484	0.0014	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—SSTR3—pancreatic cancer	0.000483	0.0014	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—DTX1—pancreatic cancer	0.000483	0.0014	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—DTX1—pancreatic cancer	0.000478	0.00139	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—SSTR3—pancreatic cancer	0.000478	0.00139	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—SST—pancreatic cancer	0.000473	0.00137	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—PTCH1—pancreatic cancer	0.00047	0.00136	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—PTHLH—pancreatic cancer	0.00047	0.00136	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—SST—pancreatic cancer	0.000468	0.00136	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—PTHLH—pancreatic cancer	0.000465	0.00135	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—PTCH1—pancreatic cancer	0.000465	0.00135	CbGpPWpGaD
Bethanechol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.000464	0.00135	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—SSTR1—pancreatic cancer	0.000463	0.00134	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—SSTR1—pancreatic cancer	0.000459	0.00133	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PPY—pancreatic cancer	0.000454	0.00132	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PPY—pancreatic cancer	0.00045	0.0013	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—SSTR2—pancreatic cancer	0.000446	0.00129	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—SSTR2—pancreatic cancer	0.000442	0.00128	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—CNR1—pancreatic cancer	0.000437	0.00127	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—CNR1—pancreatic cancer	0.000432	0.00125	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CCKBR—pancreatic cancer	0.000431	0.00125	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—SST—pancreatic cancer	0.00043	0.00125	CbGpPWpGaD
Bethanechol—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000428	0.00124	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CCKBR—pancreatic cancer	0.000426	0.00124	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—SST—pancreatic cancer	0.000425	0.00123	CbGpPWpGaD
Bethanechol—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000424	0.00123	CbGpPWpGaD
Bethanechol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.000423	0.00123	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—GCG—pancreatic cancer	0.000422	0.00122	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—GCG—pancreatic cancer	0.000418	0.00121	CbGpPWpGaD
Bethanechol—CHRM3—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.00041	0.00119	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—GLI1—pancreatic cancer	0.000405	0.00117	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—DTX4—pancreatic cancer	0.000405	0.00117	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000402	0.00117	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—DTX4—pancreatic cancer	0.000401	0.00116	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—GLI1—pancreatic cancer	0.000401	0.00116	CbGpPWpGaD
Bethanechol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.000399	0.00116	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000398	0.00116	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—CNR1—pancreatic cancer	0.000396	0.00115	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000394	0.00114	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NRP1—pancreatic cancer	0.000394	0.00114	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—CNR1—pancreatic cancer	0.000393	0.00114	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—GLP1R—pancreatic cancer	0.00039	0.00113	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.00039	0.00113	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NRP1—pancreatic cancer	0.00039	0.00113	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—DPYD—pancreatic cancer	0.000384	0.00111	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—GCG—pancreatic cancer	0.000383	0.00111	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—GCG—pancreatic cancer	0.000379	0.0011	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HEY2—pancreatic cancer	0.000379	0.0011	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HEY2—pancreatic cancer	0.000375	0.00109	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—GAST—pancreatic cancer	0.00037	0.00107	CbGpPWpGaD
Bethanechol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.000367	0.00106	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—GAST—pancreatic cancer	0.000367	0.00106	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—AGTR1—pancreatic cancer	0.000365	0.00106	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—SLC2A2—pancreatic cancer	0.000364	0.00106	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—AGTR1—pancreatic cancer	0.000362	0.00105	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—SCT—pancreatic cancer	0.000351	0.00102	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HEY1—pancreatic cancer	0.000351	0.00102	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—SCT—pancreatic cancer	0.000348	0.00101	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HEY1—pancreatic cancer	0.000348	0.00101	CbGpPWpGaD
Bethanechol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.000339	0.000984	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CCK—pancreatic cancer	0.000335	0.000971	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CCK—pancreatic cancer	0.000332	0.000962	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CNR2—pancreatic cancer	0.000326	0.000946	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—GLP1R—pancreatic cancer	0.000326	0.000946	CbGpPWpGaD
Bethanechol—CHRM3—GPCR ligand binding—CXCL8—pancreatic cancer	0.000326	0.000946	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CNR2—pancreatic cancer	0.000323	0.000937	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—GLP1R—pancreatic cancer	0.000323	0.000937	CbGpPWpGaD
Bethanechol—CHRM2—GPCR ligand binding—CXCL8—pancreatic cancer	0.000323	0.000937	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CCKAR—pancreatic cancer	0.000321	0.000931	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CCKAR—pancreatic cancer	0.000318	0.000922	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—JAG2—pancreatic cancer	0.000311	0.000903	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—JAG2—pancreatic cancer	0.000308	0.000894	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—MEN1—pancreatic cancer	0.000307	0.00089	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—MEN1—pancreatic cancer	0.000304	0.000881	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—SHH—pancreatic cancer	0.000293	0.000849	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NOTCH4—pancreatic cancer	0.000291	0.000843	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—SHH—pancreatic cancer	0.00029	0.000841	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—IAPP—pancreatic cancer	0.000289	0.000838	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NOTCH4—pancreatic cancer	0.000288	0.000835	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—IAPP—pancreatic cancer	0.000286	0.00083	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CD44—pancreatic cancer	0.000282	0.000818	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PTHLH—pancreatic cancer	0.000277	0.000805	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PTCH1—pancreatic cancer	0.000277	0.000805	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PTHLH—pancreatic cancer	0.000275	0.000797	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PTCH1—pancreatic cancer	0.000275	0.000797	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—GCG—pancreatic cancer	0.000271	0.000784	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—STK11—pancreatic cancer	0.000254	0.000738	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—SST—pancreatic cancer	0.000254	0.000736	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—SST—pancreatic cancer	0.000251	0.000729	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.00025	0.000726	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—JAG1—pancreatic cancer	0.000248	0.00072	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000248	0.000719	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NOTCH3—pancreatic cancer	0.000247	0.000717	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	0.000246	0.000713	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000245	0.00071	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CNR1—pancreatic cancer	0.000234	0.000679	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	0.000232	0.000673	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000227	0.000659	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—GCG—pancreatic cancer	0.000226	0.000656	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000225	0.000653	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—GCG—pancreatic cancer	0.000224	0.00065	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.00022	0.000638	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—TYMS—pancreatic cancer	0.000219	0.000634	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000218	0.000632	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—AGTR1—pancreatic cancer	0.000216	0.000626	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	0.000214	0.00062	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—STK11—pancreatic cancer	0.000213	0.000617	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—STK11—pancreatic cancer	0.000211	0.000611	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—PIK3CD—pancreatic cancer	0.0002	0.000579	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000198	0.000574	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000192	0.000556	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.00019	0.000551	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—SMAD4—pancreatic cancer	0.000186	0.00054	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	0.000184	0.000535	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000184	0.000534	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000183	0.000529	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HES1—pancreatic cancer	0.000182	0.000527	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HES1—pancreatic cancer	0.00018	0.000522	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—APOE—pancreatic cancer	0.000178	0.000516	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000174	0.000505	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000172	0.0005	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—CXCL8—pancreatic cancer	0.000167	0.000485	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	0.000166	0.000481	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PIK3CG—pancreatic cancer	0.000161	0.000466	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TERT—pancreatic cancer	0.000159	0.000462	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TERT—pancreatic cancer	0.000158	0.000458	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PPARG—pancreatic cancer	0.000155	0.000449	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HIF1A—pancreatic cancer	0.000152	0.000442	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TSC2—pancreatic cancer	0.000152	0.000441	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	0.000151	0.000438	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	0.000151	0.000437	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—APOE—pancreatic cancer	0.000149	0.000431	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—APOE—pancreatic cancer	0.000147	0.000427	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—KDR—pancreatic cancer	0.000146	0.000423	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—KDR—pancreatic cancer	0.000144	0.000419	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PIK3CD—pancreatic cancer	0.000141	0.000409	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	0.000139	0.000402	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	0.000137	0.000398	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	0.000137	0.000398	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	0.000136	0.000394	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	0.000134	0.000389	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	0.000134	0.000389	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	0.000133	0.000386	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	0.000133	0.000386	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—EGF—pancreatic cancer	0.000133	0.000385	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—EGF—pancreatic cancer	0.000131	0.000381	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PIK3CB—pancreatic cancer	0.000123	0.000357	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	0.000122	0.000355	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PTGS2—pancreatic cancer	0.000122	0.000354	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	0.000121	0.000351	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	0.000118	0.000342	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000117	0.000339	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	0.000117	0.000339	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000116	0.000336	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	0.000116	0.000335	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	0.000114	0.000332	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PTEN—pancreatic cancer	0.000106	0.000308	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000106	0.000308	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000105	0.000305	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	0.000103	0.000298	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	0.000102	0.000295	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	9.89e-05	0.000287	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	9.82e-05	0.000285	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	9.79e-05	0.000284	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	9.73e-05	0.000282	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	9.55e-05	0.000277	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	9.46e-05	0.000274	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	9.46e-05	0.000274	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	9.37e-05	0.000272	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	9.21e-05	0.000267	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	9.12e-05	0.000265	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	9.12e-05	0.000265	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	9.03e-05	0.000262	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	8.94e-05	0.000259	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	8.89e-05	0.000258	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	8.86e-05	0.000257	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	8.8e-05	0.000255	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	8.67e-05	0.000252	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	8.59e-05	0.000249	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—SRC—pancreatic cancer	8.24e-05	0.000239	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—SRC—pancreatic cancer	8.16e-05	0.000237	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	8.03e-05	0.000233	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	7.95e-05	0.000231	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	7.95e-05	0.000231	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	7.93e-05	0.00023	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	7.87e-05	0.000228	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	7.85e-05	0.000228	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PIK3CA—pancreatic cancer	7.5e-05	0.000218	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—MYC—pancreatic cancer	7.39e-05	0.000214	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	7.37e-05	0.000214	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—MYC—pancreatic cancer	7.32e-05	0.000212	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	7.3e-05	0.000212	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	7.23e-05	0.00021	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	7.16e-05	0.000208	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	6.83e-05	0.000198	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	6.76e-05	0.000196	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	6.27e-05	0.000182	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	6.21e-05	0.00018	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—AKT1—pancreatic cancer	6.13e-05	0.000178	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TP53—pancreatic cancer	6.07e-05	0.000176	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TP53—pancreatic cancer	6.01e-05	0.000174	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	5.8e-05	0.000168	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	5.75e-05	0.000167	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	5.12e-05	0.000149	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	5.07e-05	0.000147	CbGpPWpGaD
